[Pulmonary diseases and bone].
In the relationship between pulmonary diseases and bone, the systemic effects of pulmonary disease on bone metabolism, such as osteoporosis in COPD, have been recently investigated as well as abnormal bone metabolism induced by the therapy for lung diseases such as glucocorticoid-induced osteoporosis. However, the effective strategy for risk assessment, diagnosis and therapy of osteoporosis in lung diseases has not been established. Further studies including prospective intervention on bone metabolism in pulmonary diseases are warranted.
Department of Respiratory Medicine, Kyoto University, Japan.
Toyohiro
T
Hirai
D001842:Bone and Bones / Q000378:metabolism*; D005938:Glucocorticoids / Q000378:metabolism*; D006801:Humans; D010024:Osteoporosis / Q000150:complications / Q000175:diagnosis / Q000378:metabolism* / Q000628:therapy; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000378:metabolism*; D018570:Risk Assessment; D012307:Risk Factors
D005938:Glucocorticoids